59
Participants
Start Date
April 15, 2015
Primary Completion Date
June 29, 2017
Study Completion Date
November 20, 2017
LiRIS®
LiRIS® is a drug-device combination product which is placed in the bladder during cystoscopy and remains in the bladder, gradually releasing lidocaine until removed from the bladder via cystoscopy.
LiRIS Placebo
LiRIS placebo is a drug-device combination product, matching the LiRIS® which is placed in the bladder during cystoscopy, remains in the bladder until removed from the bladder via cystoscopy
Western New York Urology Associates, LLC, Cheektowaga
Philadelphia Urosurgical Associates, Philadelphia
Chesapeake Urology Research Associates, Baltimore
Anne Arundel Urology, P.A., Annapolis
Wake Forest Baptist Health, Winston-Salem
Eastern Urological Associates, PA, Greenville
McKay Urology, Charlotte
Atlanta Medical Research Institute, Alpharetta
MetroHealth System/Center for Advanced Gynecology, Cleveland
Beaumont Health System, Royal Oak
Beyer Research, Kalamazoo
Aurora Health Care, West Allis
Washington University School of Medicine Department of Surgery, St Louis
Tri Valley Urology Medical Group, Murrieta
Sutter Institute for Medical Research, Vacaville
University of Washington, Seattle
Women's Health Specialty Care, Farmington
Silverado Research Inc, Victoria
Sunnybrook Health Science Centre, Toronto
Lead Sponsor
Allergan
INDUSTRY